Oversight Committee Leaders Ask FDA for Documents on Proposed Generics Labeling Rule

The FDA has been asked to turn over a trove of information related to the development of its proposed generic drug labeling rule, with GOP leaders of a key House investigative committee claiming the agency engaged in “dubious” behaviors in the rulemaking process.
Generic Line